Predictive oncology reports financial results for quarter ended june 30, 2021, and provides business update

Minneapolis, aug. 11, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today reported financial results for the quarter ended june 30, 2021, and provided an update on business activities.
POAI Ratings Summary
POAI Quant Ranking